Product description

Prescription medications

See a list of details to help identify the product

Reason the product is recalled

The products have been supplied in containers without child-resistant closures. Please note that there is no concern regarding the quality or safety of this medicine other than the absence of child resistant packaging.

The hazards to consumers

If children gain access to the products there is the potential for inadvertent poisoning.

What consumers should do

Consumers are asked to return any affected product to their Pharmacy to have either the cap or the container replaced with new child resistant closures.

Details to help identify the product

Supplier running the recall

Pfizer Australia Pty Ltd

Who sold the product

Various Pharmacies nationwide

Identifying product features

Dostinex (cabergoline), Cabaser (cabergoline) & Methoblastin (methotrexate) - All Batches Dostinex (cabergoline) 0.5 mg tablet, bottles of 2 and 8 AUST R number: 52158 Cabaser (cabergoline) 1 mg tablet, bottles of 30 AUST R number: 57360 Cabaser (cabergoline) 2 mg tablet, bottles of 30 AUST R number: 57367 METHOBLASTIN (methotrexate) 2.5 mg tablets, bottles of 30 AUST R number: 15418 METHOBLASTIN (methotrexate) 10 mg tablets, bottles of 15 & 50 AUST R number: 15417

Identifying numbers

Other identifying numbers

Dostinex (cabergoline), Cabaser (cabergoline) & Methoblastin (methotrexate) - All Batches

Dostinex (cabergoline) 0.5 mg tablet, bottles of 2 and 8
AUST R number: 52158

Cabaser (cabergoline) 1 mg tablet, bottles of 30
AUST R number: 57360

Cabaser (cabergoline) 2 mg tablet, bottles of 30
AUST R number: 57367

METHOBLASTIN (methotrexate) 2.5 mg tablets, bottles of 30
AUST R number: 15418

METHOBLASTIN (methotrexate) 10 mg tablets, bottles of 15 & 50
AUST R number: 15417

Where the product was sold

Nationally

Responsible regulators

Regulators are established or appointed by government. They enforce regulations and rules.

Quote PRA number 2015/14592 when contacting a regulator about this recall.

Recall and remedy questions

Contact the Therapeutic Goods Administration if you have:

  • a question about the remedy being offered to you by the business that is responsible for managing this recall, or
  • concerns about the way the business is managing this recall.